Abstract
An increasing number of men diagnosed with localised prostate cancer has been accompanied by more men being considered for active surveillance as a management option. Here the author provides an update on recent developments in active surveillance and changes to NICE guidance.
| Original language | English |
|---|---|
| Pages (from-to) | 8-11 |
| Number of pages | 3 |
| Journal | Trends in Urology & Men's Health |
| Volume | 11 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 27 Jan 2020 |